Publications by authors named "Sameer Ghate"

Claim this Profile
I
Integrating NLP to Enhance Algorithmic Identification of Metastatic and Castration-Resistant Prostate Cancer in Large Claims-Based Studies.
Shannon R Stock, Joshua A Parrish, Michael T Burns, Jessica L Janes, Justin Waller, Sameer Ghate

Cancer Med· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-reported Outcomes in KEYLYNK-010: Pembrolizumab Plus Olaparib Versus Abiraterone or Enzalutamide for Participants with Biomarker-unselected, Previously Treated Metastatic Castration-resistant Prostate Cancer.
Niven Mehra, Emmanuel S Antonarakis, Se Hoon Park, Jeffrey C Goh, Ray McDermott, Sameer R Ghate

Eur Urol Oncol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-reported Outcomes in KEYNOTE-921: Pembrolizumab with Docetaxel and Prednisone for Patients with Metastatic Castration-resistant Prostate Cancer.
Nobuaki Matsubara, Daniel Petrylak, Raffaele Ratta, Ernesto Korbenfeld, Rustem Gafanov, Sameer R Ghate

Eur Urol Oncol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world treatment patterns and genetic testing in a metastatic castration-resistant prostate cancer setting in Europe.
Elena Castro, Chinelo Orji, Amanda Ribbands, Jake Butcher, Maria Walley, Sameer R Ghate

Future Oncol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epidemiology, treatment patterns, and clinical outcomes in de novo oligometastatic hormone-sensitive prostate cancer.
Jun Gong, Jessica L Janes, Claire Trustram Eve, Shannon Stock, Justin Waller, Sameer R Ghate

Cancer· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Racial and Ethnic Differences in Prostate Cancer Epidemiology Across Disease States in the VA.
Shannon R Stock, Michael T Burns, Justin Waller, Amanda M De Hoedt, Joshua A Parrish, Sameer Ghate

JAMA Netw Open· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Treatment Patterns in Metastatic Castration-Resistant Prostate Cancer Across Europe (France, Germany, Italy, Spain, and the United Kingdom) and Japan.
Andrea Leith, Jeri Kim, Amanda Ribbands, Emily Clayton, Lingfeng Yang, Sameer R Ghate

Adv Ther· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world homologous recombination repair mutation testing in metastatic castration-resistant prostate cancer in the USA, Europe and Japan.
Andrea Leith, Amanda Ribbands, Jeri Kim, Matthew Last, Sophie Barlow, Sameer R Ghate

Future Oncol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of next-generation hormonal agents on treatment patterns among patients with metastatic hormone-sensitive prostate cancer: a real-world study from the United States, five European countries and Japan.
Andrea Leith, Amanda Ribbands, Jeri Kim, Emily Clayton, Liane Gillespie-Akar, Sameer R Ghate

BMC Urol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Beyond Frontline Therapy with Abiraterone and Enzalutamide in Metastatic Castration-Resistant Prostate Cancer: A Real-World US Study.
Neal D Shore, Raluca Ionescu-Ittu, François Laliberté, Lingfeng Yang, Dominique Lejeune, Sameer R Ghate

Clin Genitourin Cancer· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring the Impact of Treatment Switching on Overall Survival from the PROfound Study in Homologous Recombination Repair (HRR)-Mutated Metastatic Castration-Resistant Prostate Cancer (mCRPC).
Rachel Evans, Neil Hawkins, Pascale Dequen-O'Byrne, Charles McCrea, Dominic Muston, Sameer R Ghate

Target Oncol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world genetic testing patterns in metastatic castration-resistant prostate cancer.
Neal Shore, Raluca Ionescu-Ittu, Lingfeng Yang, François Laliberté, Malena Mahendran, Sameer R Ghate

Future Oncol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Treatment Patterns and Overall Survival of Patients with Metastatic Castration-Resistant Prostate Cancer in the US Prior to PARP Inhibitors.
Neal D Shore, François Laliberté, Raluca Ionescu-Ittu, Lingfeng Yang, Malena Mahendran, Sameer R Ghate

Adv Ther· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systematic Literature Review of the Epidemiology of Advanced Prostate Cancer and Associated Homologous Recombination Repair Gene Alterations.
Neal Shore, Louisa Oliver, Irene Shui, Alicia Gayle, On-Ye Wong, Sameer Ghate

J Urol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of dabrafenib and trametinib in combination as adjuvant treatment of BRAF V600E/K mutation-positive melanoma from a US healthcare payer perspective.
Margaret E Gerbasi, Daniel Stellato, Sameer R Ghate, Briana Ndife, Aaron Moynahan

J Med Econ· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Budget Impact of Dabrafenib and Trametinib in Combination as Adjuvant Treatment of BRAF V600E/K Mutation-Positive Melanoma from a U.S. Commercial Payer Perspective.
Daniel Stellato, Margaret E Gerbasi, Briana Ndife, Sameer R Ghate, Aaron Moynahan

J Manag Care Spec Pharm· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted agents or immuno-oncology therapies as first-line therapy for BRAF-mutated metastatic melanoma: a real-world study.
Jason J Luke, Sameer R Ghate, Jonathan Kish, Choo Hyung Lee, Lindsay McAllister

Future Oncol· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patterns of treatment and BRAF testing with immune checkpoint inhibitors and targeted therapy in patients with metastatic melanoma presumed to be BRAF positive.
Sameer Ghate, Raluca Ionescu-Ittu, Rebecca Burne, Briana Ndife, François Laliberté

Melanoma Res· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient preferences for treatment of metastatic melanoma.
Carol Mansfield, Briana Ndife, Joyce Chen, Kathleen Gallaher, Sameer Ghate

Future Oncol· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stage III melanoma incidence and impact of transitioning to the 8th AJCC staging system: a US population-based study.
Ahmad Tarhini, Sameer Ghate, Raluca Ionescu-Ittu, Sherry Shi, Antonio Nakasato

Future Oncol· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Healthcare resource utilization in patients with metastatic melanoma receiving first-line therapy with dabrafenib + trametinib versus nivolumab or pembrolizumab monotherapy.
Sameer R Ghate, Raluca Ionescu-Ittu, Rebecca Burne, Briana Ndife, François Laliberté

Curr Med Res Opin· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Postsurgical treatment landscape and economic burden of locoregional and distant recurrence in patients with operable nonmetastatic melanoma.
Ahmad Tarhini, Sameer R Ghate, Raluca Ionescu-Ittu, Ameur M Manceur, Briana Ndife

Melanoma Res· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Economic Burden of Adverse Events Associated with Immunotherapy and Targeted Therapy for Metastatic Melanoma in the Elderly.
Sameer R Ghate, Zhiyi Li, Jackson Tang, Antonio Reis Nakasato

Am Health Drug Benefits· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of Long-Term Response With Pazopanib in Patients With Advanced Renal-Cell Carcinoma.
Jinhee Park, Xiaolong Jiao, Sameer Ghate, Thomas Wilson, Qasim I Ahmad

Clin Genitourin Cancer· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Economic Outcomes During Time on Treatment Among Patients Who Initiated Sunitinib or Pazopanib as First Targeted Therapy for Advanced Renal Cell Carcinoma: A Retrospective Analysis of Medicare Claims Data.
Nicholas J Vogelzang, Sumanta K Pal, Sameer R Ghate, Nanxin Li, Elyse Swallow

J Manag Care Spec Pharm· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis